Patent details

EP2994148 Title: CANCER THERAPY

Basic Information

Publication number:
EP2994148
PCT Application Number:
PCT/GB/2014/051421
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147238646
PCT Publication Number:
WO/2014/181121
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CANCER THERAPY
French Title of Invention:
THÉRAPIE DU CANCER
German Title of Invention:
KREBSTHERAPIE
SPC Number:

Dates

Filing date:
09/05/2014
Grant date:
01/02/2017
EP Publication Date:
01/02/2017
PCT Publication Date:
13/11/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/03/2016
EP B1 Publication Date:
01/02/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/05/2017
Expiration date:
09/05/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/05/2014
 
 

Name:
Immodulon Therapeutics
Address:
475 Salisbury House, London Wall London EC2M 5QQ, United Kingdom (GB)

Inventor

Name:
HAGEMANN Thorsten
Address:
United Kingdom (GB)

Priority

Priority Number:
201308325
Priority Date:
09/05/2013
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 35/74;

Publication

European Patent Bulletin

Issue number:
201735
Publication date:
30/08/2017
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages